|
|
||||||||
HORMONES AND SIGNALING
Center for Surgical Research and Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama 35294-0019
Submitted 18 August 2003 ; accepted in final form 9 October 2003
| ABSTRACT |
|---|
|
|
|---|
-estradiol (E2)-treated noncastrated male rats were studied. Dose response curves to ACh and nitroglycerin (NTG) were determined by measuring changes in perfusion pressure by using an isolated small intestinal perfusion model. Endothelium-derived nitric oxide (NO) production/release was indirectly determined by the ability of intact endothelium to suppress serotonin (10-5 M)-induced perfusion pressure changes. Intestinal tissue levels of NO were also measured. Moreover, plasma levels of androgen and E2 were determined and correlated with ACh (10-8 M)-induced perfusion pressure reductions. ACh-induced intestinal perfusion pressure reductions in proestrus females, castrated males, and E2-treated noncastrated males were significantly higher than in untreated males. NTG-induced perfusion pressure reductions were not significantly different among groups. Perfusion pressures after administration of serotonin (10-5 M) and intestinal tissue levels of NO in proestrus females, castrated males, and E2-treated noncastrated males were also significantly higher than in untreated males. Plasma androgen levels in proestrus females, castrated males, and in E2-treated noncastrated males were significantly lower compared with untreated males. There was a positive correlation between plasma androgen and ACh-reduced perfusion pressure; however, E2 levels did not show a similar relationship. Thus androgens appear to play an inhibitory role in small intestinal endothelial function. These properties in male vessels can be modulated by decreasing the level of circulating androgens or by E2 treatment.
male; female; endothelium; acetylcholine; serotonin; nitroglycerin
It is well established that gender directly influences the cardiovascular system (28, 31). Clinical studies have shown that the incidence of coronary artery disease and systemic hypertension are higher in men than in age-matched premenopausal women (26). Furthermore, Kauser et al. (24) indicated that sex steroid hormones can influence endothelial function in isolated rat aorta, which may contribute to gender differences observed in the pathogenesis of cardiovascular diseases. Experimental data indicate that vascular endothelial function is gender dimorphic (5). In this regard, it has been shown that testosterone receptor blockade after trauma-hemorrhage improves the depressed cardiac, hepatic, and adrenal functions in male rats (7, 32). Estradiol has been demonstrated to directly relax blood vessels or facilitate the relaxation in response to other vasoconstrictive agents (28). We have previously shown that there are gender differences in the intestinal perfusion pressure reduction after trauma and hemorrhagic shock. However, little is known about the possible effects of sex steroids on small intestinal vascular endothelial function. In light of these previous findings, we hypothesized that differences exist in endothelial function of male and proestrus female animals. To test this, small intestinal vascular endothelial function was determined in male, age-matched proestrus female, castrated male, and noncastrated male rats treated with 17
-estradiol (E2) by using an isolated intestinal perfusion system. In addition, plasma levels of androgen and estrogen were measured and correlated with the observed parameters.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Isolated small intestine and measurement of ACh or NTG-induced small intestinal vessel relaxation. Animals underwent an isolated small intestinal perfusion model as described previously by Ba et al. (5). Briefly, the right femoral vein was cannulated under isoflurane (1.5% with air) anesthesia, and the anesthesia was maintained by injection of pentobarbital sodium (30 mg/kg body wt) via the femoral vein. After intravenous injection of 0.5 ml heparin (500 units), the small intestine was isolated in situ. The superior mesenteric artery and portal vein were cannulated with polyethylene (PE)-50 and PE-90 tubing, respectively. Branches of blood vessels to and from the colon were then ligated. The isolated intestine was then perfused with aerated (95% O2-5% CO2, 37°C) Krebs-Ringer HCO3 buffer through the superior mesenteric artery catheter (PE-50). Dextran 70 (6%; Sigma, St. Louis, MO) was added to the buffer to prevent intestinal edema. After 30-min equilibration at a constant perfusion rate of 5 ml/min, perfusion pressure was 28.7 ± 2.1 mmHg. Blood vessels were then contracted in the isolated intestine with 5 x 10-6 M norepinephrine (NE), which increased perfusion pressure to 117.56 ± 5.84 mmHg. Vascular responses to ACh were determined by measuring changes in perfusion pressure in isolated small intestine. Intestinal preparations were viable throughout the study period as determined by the similar rise in the NE-induced increase in perfusion pressure at the end of the experiments.
Indirect determination of endothelium-derived nitric oxide production. Baseline production of endothelium-derived nitric oxide (NO) was indirectly evaluated by determining the ability of intact endothelium to suppress serotonin (10-5 M)-induced perfusion pressure. Isolated intestine was prepared as described above. After the 10-min equilibration at a constant perfusion rate of 5 ml/min, vascular response to serotonin (10-5 M) was measured with or without N
-nitro-L-arginine (L-NNA; an inhibitor of endothelium-derived NO production) in the isolated intestine. The extent of changes in perfusion pressure in response to serotonin reflects the amount of endothelium-derived NO produced.
Tissue nitrate/nitrite levels. Production of NO from the small intestine was further evaluated by measuring tissue nitrate/nitrite levels by using a commercially available colorimetric assay kit (Cayman Chemical, Ann Arbor, MI). A piece of tissue was taken from small intestine, immediately placed in liquid nitrogen, and stored at -80°C until assayed. Tissue samples (1 mg wet wt) were homogenized in 1 ml of PBS (pH 7.4) in an ice bath and centrifuged at 2,000 g for 20 min. The supernatant (250 µl) was further centrifuged by using a 30-kDa molecular mass cut-off filter (Fisher Scientific, Pittsburgh, PA) prerinsed with HPLC grand water and centrifuged at 42,000 g for 60 min (Beckman Avanti J-251; Beckman Coulter, Palo Alto, CA). The outflow was analyzed according to the manufacturer's description.
Determination of plasma androgen and estrogen levels. Blood samples (23 ml) were obtained by cardiac puncture and centrifuged at 1,600 g for 15 min at 4°C to separate plasma. Plasma was immediately stored in a freezer (-80°C) until assayed. The assay for plasma E2 was performed by using commercially available estradiol enzyme immunoassay (EIA) kit (Cayman Chemical). Plasma androgen levels were expressed as the sum of testosterone and dihydrotestosterone (DHT) and were determined by using a commercially available testosterone EIA kit (Cayman Chemical) and a DHT EIA kit (ALPCO Diagnostics, Windham, NH), respectively.
Statistical analysis. All data are presented as means ± SE. Vascular responses were expressed as percent reduction of the initial vascular tension that was induced by 5 x 10-6 M NE in the isolated small intestine. One-way ANOVA and Tukey's test were used for comparison among groups, and the differences were considered significant at P < 0.05. The correlation indexes (R2) between androgen and estrogen levels and the ACh-induced intestinal perfusion pressure percent changes were calculated by regression analysis in Corel Quattro.
| RESULTS |
|---|
|
|
|---|
|
ACh and NTG-induced perfusion pressure reduction in isolated intestine. ACh-induced intestinal perfusion pressure reduction was significantly greater in females, castrated males, and E2-treated males than in untreated males at the examined concentrations of ACh (Fig. 1A). However, the difference in NTG-induced perfusion pressure reduction was not significant among these groups at the tested NTG concentrations (Fig. 1B).
|
Pressure responses to serotonin in the isolated intestine. Serotonin induced a significantly diminished intestinal perfusion pressure increase in females, castrated males, and E2-treated noncastrated males than in untreated males (Fig. 2A). However, these differences could not be observed when the NO synthase inhibitor L-NNA was used in the perfusate in addition to serotonin (Fig. 2B). Differences in serotonin-induced and L-NNA-induced intestinal perfusion pressure reduction revealed that the suppression in perfusion pressures with intact endothelium was significantly lower in untreated males than among females, castrated males, and E2-treated noncastrated males. It indirectly indicates that the NO release in intact endothelium is decreased in untreated males compared with females, castrated males, and E2-treated noncastrated males (Fig. 2C).
|
Intestinal tissue NO levels. The observed intestinal tissue NO levels were significantly higher in females, castrated males, and E2-treated noncastrated males than in untreated males (Fig. 3).
|
Correlation between the plasma sex steroid levels and ACh-induced perfusion pressure reduction. There was a positive correlation between plasma androgen levels and ACh (10-8 M)-induced intestinal perfusion pressure reductions (R2 = 0.698) (Fig. 4A). However, we did not observe a similar correlation between plasma E2 levels and ACh-induced intestinal perfusion pressure reductions (Fig. 4B).
|
| DISCUSSION |
|---|
|
|
|---|
Marked differences were observed in the reactivity of the intestinal vessel bed to ACh, which is an endothelium-dependent vasodilator (5, 6, 39). Male rats showed significant pressure reductions compared with proestrus females, castrated males, and normal intact males with E2 treatment. However, there was no difference among the responses of the proestrus female, castrated males, and noncastrated males treated with E2. The pressure reduction generated by NTG (an endothelium-independent vasodilator) was not significantly different among the groups. Moreover, the perfusion pressure by intact endothelium after serotonin treatment was significantly greater in proestrus females than in males. Additionally, intestinal tissue NO levels in proestrus females were significantly higher than in males. However, not only did the proestrus female animals show significantly greater ACh-induced isolated intestinal perfusion pressure reduction, but similar differences were observed in castrated males and E2-treated males as well. Furthermore, there was a correlation between the plasma levels of androgen and ACh-induced intestinal perfusion pressure reduction. We therefore postulate that the observed decreased pressure reduction in males, compared with proestrus females, castrated males, and noncastrated males with E2 treatment, are at least partly mediated by differences in the endothelial function. Because there was no difference among the responses of the proestrus female, castrated males, and noncastrated males with E2 treatment after NTG treatment, it appears that such gender differences are due to sex hormone levels. In this regard, our data support the hypothesis that not only high E2 levels but also the ratio of androgen/estrogen contributes to the observed changes in the endothelial function. In males, the androgen/estrogen ratio is extremely high compared with the castrated groups and the proestrus females. This high ratio is accompanied by a decreased pressure reduction. In proestrus females, castrated males, and E2-treated noncastrated males, the androgen levels were low, and those were associated with a higher endothelial response. It therefore appears that not only the high E2 levels but also the low androgen-to-estrogen ratio plays an important role in the female-like endothelial responses as well. Thus our results show gender-specific differences in the function of the intestinal vasculature. However, to determine the potential therapeutic applications of these findings, the underlying mechanisms must be elucidated.
The observed beneficial effects of E2 treatment on endothelial function can be explained as the consequence of direct or indirect actions of this sex steroid. E2 can increase the release of prolactin and thus exert indirect actions (42). The direct effects can be generated via two different types of E2 receptors: estradiol receptor-
and estradiol receptor-
. The contribution of these receptor subtypes should be determined. Another possibility could be the use of an androgen receptor antagonist in males. In this regard, flutamide has been shown to imitate the immunomodulatory effects of castration (40) and to improve cardiac and hepatocellular functions after trauma and hemorrhagic shock (32). Whether or not flutamide has any effects on endothelial response remains to be determined.
Whereas it is widely recognized that men are generally more susceptible to coronary artery diseases compared with women, studies have paid little attention to the effects of androgens on the vasculature. In this regard, Herman et al. (18) reported that androgen deprivation in adult men enhanced endothelium-dependent relaxation. Furthermore, administration of testosterone in hypercholesterolemic rabbits and monkeys impaired endothelium-dependent relaxation and promoted the progression of atherosclerosis (1, 19). Previous studies (2, 16, 23, 25, 27, 43) have shown that there are gender differences in vascular reactivity. Moreover, studies (10, 12, 22, 29, 36) have shown that sex hormones can alter the sensitivity of blood vessels to different agonists. However, these studies were focused on large vessels. A possible influence of sex steroids on the cardiovascular system has also been shown in the incidence of atherosclerosis or the risk of cardiovascular diseases (20). However, these studies were focused on the gender differences in endothelial function in large vessels, such as aorta. The functional differences between large and small vessels can be significant. To our best knowledge, the present study is the first to report that there are significant gender differences in small intestinal endothelial function under normal physiological conditions.
It has been previously documented that the release of endothelium-derived NO from endothelial cells contributes to vascular dilatation and that the tissue level of NO directly correlates to endothelial functions (13). Furthermore, prior studies (9, 16, 22, 37, 41) suggest that the gender differences in NO production may be due to the effect of estrogens on endothelium. In this regard, it has been shown that the basal release of NO is significantly augmented by estrogen in the aorta of ovariectomized rabbits, although circulating L-arginine concentrations are not different (16). Moreover, intra-arterial infusion of estrogen into the uterine artery of sheep produced vasodilation and increased uterine blood flow, which could be inhibited by an L-arginine analog, suggesting that NO mediated the effect (37). Proestrus females, castrated males, and noncrastrated E2-treated male animals had significantly higher NO levels measured by nitrate/nitrite levels in our experiments. On the basis of these results and our previous data, it could be speculated that one possible factor contributing to the enhanced relaxation compared with males might be the increased NO production. However, further experiments are required to determine the exact underlying mechanisms.
In conclusion, our results indicate that the endothelium-dependent (ACh-induced) intestinal perfusion pressure reduction in males was significantly lower than in proestrus females. This effect can be reversed by gonadectomy or estrogen treatment. Furthermore, the observed correlation between androgen plasma levels and ACh-induced perfusion pressure suggest that androgens can influence intestinal endothelial function. The increased endothelial pressure reduction might be at least partly due to the increased NO production in proestrus females, castrated males, and noncastrated E2-treated males. The observed changes in the small intestinal vasculature could thus represent a potential mechanism for the circulatory gender differences between males and females.
| ACKNOWLEDGMENTS |
|---|
This investigation was supported by National Institute of General Medical Sciences Grant R37-GM-39519 (I. H. Chaudry).
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
-adrenergic receptor affinity in female and estrogen-treated male rats. Circ Res 50: 805-811, 1982.
-Estradiol augments endothelium-dependent contractions to arachidonic acid in rabbit aorta. Am J Physiol Regul Integr Comp Physiol 258: R1502-R1507, 1990.This article has been cited by other articles:
![]() |
Z. F. Ba and I. H. Chaudry Role of estrogen receptor subtypes in estrogen-induced organ-specific vasorelaxation after trauma-hemorrhage Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2061 - H2067. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Baccari, S. Nistri, M. G. Vannucchi, F. Calamai, and D. Bani Reversal by relaxin of altered ileal spontaneous contractions in dystrophic (mdx) mice through a nitric oxide-mediated mechanism Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R662 - R668. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. F. Ba, T. Shimizu, L. Szalay, K. I. Bland, and I. H. Chaudry Gender differences in small intestinal perfusion following trauma hemorrhage: the role of endothelin-1 Am J Physiol Gastrointest Liver Physiol, May 1, 2005; 288(5): G860 - G865. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |